Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher McCarthy Insider Profile
11 Followers
Christopher McCarthy, CFO at Interpace Diagnostics Group, holds 45.64K shares in Interpace Diagnostics Group (Ticker: IDXG).
Christopher McCarthy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher McCarthy's holdings
Insider Roles
CFO
Roles that Christopher McCarthy holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher McCarthy
Christopher McCarthy's Trading History
List of latest transactions for each holding click on a transaction to see Christopher McCarthy's performance on stock
You May Also Like
Christopher McCarthy insider profile FAQ
What is the percentage of profitable transactions made by Christopher McCarthy?
The percentage of profitable transactions made by Christopher McCarthy is ―.
What is the average return per transaction made by Christopher McCarthy?
The average return per transaction made by Christopher McCarthy is ―.
What stocks does Christopher McCarthy hold?
Christopher McCarthy holds: IDXG stocks.
What was Christopher McCarthy’s latest transaction?
Christopher McCarthy latest transaction was an Uninformative Buy of ―.
What was Christopher McCarthy's most profitable transaction?
Christopher McCarthy’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher McCarthy's role in Interpace Diagnostics Group?
Christopher McCarthy's role in Interpace Diagnostics Group is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.